Company / Gross Profit per Share
Perspective Therapeutics, Inc. Gross Profit per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
-
FY2022
5-year range
$0.00 / $0.04
FY2018-FY2022
Trend
-100.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.03 to $0.00 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, gross profit per share decreased 100.0% year-over-year.
- Peak gross profit per share was recorded in FY2021.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.04 | +61.8% |
| FY2020 | $0.03 | +83.7% |
| FY2019 | $0.01 | +534.5% |
| FY2018 | $0.00 | -22.8% |
| FY2017 | $0.00 | +164.2% |
| FY2016 | -$0.00 | -230.8% |
| FY2015 | $0.00 | -16.7% |
| FY2014 | $0.00 | -80.9% |
| FY2013 | $0.02 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026